Farnesylated Protein Converting Enzyme 2 (FACE2)

[Edit]

RCE1; RCE1A; RCE1B; RCE1 Homolog,Prenyl Protein Peptidase; CAAX Prenyl Protease 2; Prenyl Protein-Specific Endoprotease 2

Farnesylated Protein Converting Enzyme 2 (FACE2)
FACE2encodes an integral membrane protein which is classified as a member of the metalloproteinase family. This enzyme is thought to function in the maintenance and processing of CAAX-type prenylated proteins.
RCE1 encodes a deduced 329-amino acid protein that shares 42% identity over 105 amino acids with the yeast protein and contains several predicted transmembrane domains. RCE1 transcript in heart, brain, placenta, lung, liver, muscle, kidney, and pancreas. A weaker 2.4-kb transcript was also detected in some tissues. Northern blot analysis of mouse tissues revealed broad expression and multiple transcript sizes.The partial recombinant human RCE1 clone used all forms of Ras as substrates, suggesting that the enzyme can use a broad range of CAAX-type prenyl protein substrates.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Farnesylated Protein Converting Enzyme 2 (FACE2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Farnesylated Protein Converting Enzyme 2 (FACE2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Farnesylated Protein Converting Enzyme 2 (FACE2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Farnesylated Protein Converting Enzyme 2 (FACE2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Farnesylated Protein Converting Enzyme 2 (FACE2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Farnesylated Protein Converting Enzyme 2 (FACE2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Farnesylated Protein Converting Enzyme 2 (FACE2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Farnesylated Protein Converting Enzyme 2 (FACE2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Farnesylated Protein Converting Enzyme 2 (FACE2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Farnesylated Protein Converting Enzyme 2 (FACE2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Farnesylated Protein Converting Enzyme 2 (FACE2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Farnesylated Protein Converting Enzyme 2 (FACE2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Farnesylated Protein Converting Enzyme 2 (FACE2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Farnesylated Protein Converting Enzyme 2 (FACE2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Farnesylated Protein Converting Enzyme 2 (FACE2) ELISA Kit Customized Service Offer
  1. "Identification and chromosomal location of two human genes encoding enzymes potentially involved in proteolytic maturation of farnesylated proteins."Genomics 58:270-280(1999) [PubMed] [Europe PMC] [Abstract]
  2. "Cloning and characterization of a mammalian prenyl protein-specific protease."J. Biol. Chem. 274:8379-8382(1999) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Human ras-converting enzyme (hRCE1) endoproteolytic activity on K-ras-derived peptides."Anal. Biochem. 286:129-137(2000) [PubMed] [Europe PMC] [Abstract]
  5. "USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity."J. Biol. Chem. 284:9587-9595(2009) [PubMed] [Europe PMC] [Abstract]
  6. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  7. "The consensus coding sequences of human breast and colorectal cancers." Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract]